Suboptimal Response to Tenofovir Alafenamide in Two Patients With HBeAg-Positive Hepatitis B: A Case Report

Suboptimal Response to Tenofovir Alafenamide in Two Patients With HBeAg-Positive Hepatitis B: A Case Report

Tenofovir alafenamide (TAF) is one of the most potent first-line nucleot(s)ide analogs for treating chronic hepatitis B virus (HBV) infections. To date, no cases of TAF drug resistance and/or suboptimal response have been reported. To our knowledge, this is the first report of two adult male patient...

Full description

Bibliographic Details
Main Authors:	Ruochan Chen, Siya Pei, Yayu Chen, Linxia Tan, Ying Xue, Shao Liu, Yan Huang, Xuegong Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Medicine
Subjects:	tenofovir alafenamide suboptimal response HBeAg-positive chronic hepatitis B monotherapy case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.701061/full

Similar Items

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
by: Ayub Al Mamun, et al.
Published: (2013-01-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
by: Xiaomei Wang, et al.
Published: (2020-10-01)

Comparison of evolutionary patterns of different HBeAg status in HBV genotype B and C
by: Cai Ying, et al.
Published: (2015-12-01)

Immunomodulatory Function of HBeAg Related to Short-Sighted Evolution, Transmissibility, and Clinical Manifestation of Hepatitis B Virus
by: Anna Kramvis, et al.
Published: (2018-10-01)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Published: (2006-01-01)

What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
by: Kadir Demir, et al.
Published: (2007-04-01)

Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections
by: Weiqiang Gan, et al.
Published: (2020-12-01)

Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
by: Su-Ru Lin, et al.
Published: (2021-06-01)

Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia
by: Flamir da Silva Victoria, et al.

Soroconversão tardia do HBeAg em portadores do subgenótipo D4 do vírus da hepatite B
by: Souza, Marinilde Teles
Published: (2017)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
by: Cheng-Yuan Peng, et al.
Published: (2015-04-01)

¿A quién tratar?
by: Marianella Madrigal-Borloz
Published: (2008-11-01)

Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study
by: Yi-Cheng Chen, et al.
Published: (2020-05-01)

HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b
by: Hui Ma, et al.
Published: (2016-01-01)

Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women
by: Erry Gumilar Dachlan, et al.
Published: (2020-10-01)

Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients
by: Yu Cui, et al.
Published: (2019-06-01)

Plasma Level of ADAMTS13 or IL-12 as an Indicator of HBeAg Seroconversion in Chronic Hepatitis B Patients Undergoing m-ETV Treatment
by: Jiezuan Yang, et al.
Published: (2020-07-01)

The Relationship between Intrahepatic Distribution of Hepatitis B Virus Core Antigen and Serum ALT, HBV DNA Levels and HBeAg Status
by: He Qing, et al.
Published: (2012-06-01)

Status of Hepatitis Be Antigen in Chronic Hepatitis B Patients from Various Regions of Pakistan
by: Agha Babar Hussain
Published: (2017-09-01)

A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon
by: Kfutwah Anfumbom KW, et al.
Published: (2012-03-01)

HBeAg-negative chronic hepatitis
by: M M Ibragimova, et al.
Published: (2004-02-01)

Naturally Occurring Mutations within HBV Surface Promoter II Sequences Affect Transcription Activity, HBsAg and HBV DNA Levels in HBeAg-Positive Chronic Hepatitis B Patients
by: Ran Hao, et al.
Published: (2019-01-01)

The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions
by: Ott Jördis J, et al.
Published: (2012-06-01)

Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
by: Na Yang, et al.
Published: (2021-08-01)

Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy
by: Chenyu Xu, et al.
Published: (2018-07-01)

Response of Preterm Infants of Mothers Who Are Chronic Carriers of Both HBsAg and HBeAg to Pre-52 Containing Hepatitis 8 Vaccine (TGP 943) - A Preliminary Report
by: Abdul Hamid Sutohardjo
Published: (2018-10-01)

A scoring model predicts hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with nucleos(t)ide analogs: real-world clinical practice
by: Mingfan Geng, et al.
Published: (2017-09-01)

SERUM HSP 70 LEVELS OF CHRONIC HEPATITIS B PATIENTS ARE SUBSTANTIALLY CORRELATED WITH HBsAg
by: Awaz Saadi
Published: (2020-05-01)

Combination of Peginterferon α-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B-an Indian experience
by: Deepak N. Amarapurkar, et al.
Published: (2005-01-01)

Detection of Hepatitis -B virus Genotypes among Chronic Carriers in Duhok - Iraq
by: Ibrahim M. Abdulla, et al.
Published: (2016-07-01)

Frequency of HBsAg in pregnant women in Gorgan, Iran
by: Cheraghali F (MD), et al.
Published: (2012-01-01)

Hepatitis B and NAFLD: Lives Crossed
by: María Luisa Morales,, et al.
Published: (2017-03-01)

The effect of patients with chronic hepatitis B HBeAg（+）with poor response to treatment by converting to sequential treatment with tenofovir dipivoxil
by: Zhi-Xiong Liao
Published: (2020-03-01)

Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women
by: Ling-Ling Lu, et al.
Published: (2014-11-01)

Viral Biomarkers in Chronic HBeAg Negative HBV Infection
by: Emilia Hadziyannis, et al.
Published: (2018-09-01)

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
by: Nicholas T. Funderburg, et al.
Published: (2016-11-01)

Hepatitis B sero-markers evaluation in People born in 1989 in Zabol
by: eraj Shahramian, et al.
Published: (2009-03-01)

Response predictors to treatment with pegylated interferon in chronic hepatitis B
by: Paulo Roberto Abrão Ferreira, et al.

Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha‐fetoprotein assessment
by: Hitoshi Tajiri, et al.
Published: (2016-11-01)

The human C-type lectin 18 is a potential biomarker in patients with chronic hepatitis B virus infection
by: Tsung-Yu Tsai, et al.
Published: (2018-07-01)

Cannot write session to /tmp/vufind_sessions/sess_eeiigg1b1so2qltsagudn3239c